252210-01-8

Basic information

• Product Name: DiMethyl 5-ChloroMethyl-1,3-Benzene-Dicarboxylate
• Synonyms: DiMethyl 5-ChloroMethyl-1,3-Benzene-Dicarboxylate
• CAS NO: 252210-01-8
• Molecular Formula: C₁₁H₁₁ClO₄
• Molecular Weight: 242.65564
• Mol File: 252210-01-8.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 362.0±37.0 °C(Predicted)
• Appearance: /
• Density: 1.257±0.06 g/cm3(Predicted)
• CAS DataBase Reference: DiMethyl 5-ChloroMethyl-1,3-Benzene-Dicarboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: DiMethyl 5-ChloroMethyl-1,3-Benzene-Dicarboxylate(252210-01-8)
• EPA Substance Registry System: DiMethyl 5-ChloroMethyl-1,3-Benzene-Dicarboxylate(252210-01-8)

Safety Data

• Hazardous Substances Data: 252210-01-8(Hazardous Substances Data)

Usage

General Description

DiMethyl 5-ChloroMethyl-1,3-Benzene-Dicarboxylate is a chemical compound with the molecular formula C11H11ClO4. It is a diester of chloromethyl phthalic acid and is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. DiMethyl 5-ChloroMethyl-1,3-Benzene-Dicarboxylate is known for its potential applications in the production of active pharmaceutical ingredients and is often used as a building block in organic synthesis. Additionally, it has been identified as a potential substrate for enzyme-catalyzed reactions, making it a valuable tool in the field of biocatalysis. Due to its unique chemical structure, DiMethyl 5-ChloroMethyl-1,3-Benzene-Dicarboxylate has the potential to be used in a wide range of chemical and pharmaceutical processes.

Upstream product

• 109862-53-5 dimethyl 5-hydroxymethylbenzene-1,3-dicarboxylate 
• 554-95-0 benzene-1,3,5-tricarboxylic acid 
• 2672-58-4 1,3,5-tris-(methoxycarbonyl)benzene 
• 38588-64-6 3,5-bis(methoxycarbonyl)benzoic acid 

Downstream Products

• 178056-30-9 dimethyl 5-azidomethylbenzene-1,3-dicarboxylate 
• 252210-03-0 5-(azidomethyl)benzene-1,3-dicarbonyl dichloride 
• 252210-02-9 5-azidomethylbenzene-1,3-dicarboxylic acid 
• 252210-12-1 Acetic acid (2R,3R,4S,5S,6S)-3,5-diacetoxy-2-acetoxymethyl-6-(3-{3-aminomethyl-5-[3-((2S,3S,4S,5R,6R)-3,4,5-triacetoxy-6-acetoxymethyl-tetrahydro-pyran-2-yloxy)-propylcarbamoyl]-benzoylamino}-propoxy)-tetrahydro-pyran-4-yl ester 
• 252210-08-5 5-azidomethyl-N,N'-bis[3-O-(2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl)propyl]benzene-1,3-dicarboxamide 
• 937371-89-6 QAD-3 
• 1220529-82-7 dimethyl 5-(azidomethyl)isophthalate 
• 1206724-92-6 5-(((tert-butoxycarbonyl)amino)methyl)isophthalic acid 

Relevant articles and documents

BIVALENT TARGETED CONJUGATES

The invention provides conjugates that comprise a bivalent targeting moiety, a nucleic acid, and optional linking groups as well as synthetic intermediates and synthetic methods useful for preparing the conjugates, compositions comprising the bidentate targeting ligands and the conjugates, as well as methods for targeting therapeutic nucleic acids with the bidentate conjugates. The conjugates are useful to target therapeutic nucleic acids.

Radiolabeled Dibenzodiazepinone-Type Antagonists Give Evidence of Dualsteric Binding at the M2 Muscarinic Acetylcholine Receptor

The dualsteric ligand approach, aiming at ligands with improved subtype selectivity, has been increasingly applied to muscarinic receptors (MRs). In this article, we present the synthesis and characterization of a M2R subtype-preferring radiola

Peptide dendrimers with designer core for directed self-assembly

A series of designer peptide dendrimers with urea and urea-triazole cores were synthesized. Urea cored dendrimers assembled into fibrillar morphology, while dendrimers with urea-triazole core assembled into vesicular morphology. The core-dependent self-as